1-(3-Bromo-pyridin-2-yl)-4-methyl-piperazine

ID: ALA50017

Cas Number: 87394-59-0

PubChem CID: 12203911

Max Phase: Preclinical

Molecular Formula: C10H14BrN3

Molecular Weight: 256.15

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ncccc2Br)CC1

Standard InChI:  InChI=1S/C10H14BrN3/c1-13-5-7-14(8-6-13)10-9(11)3-2-4-12-10/h2-4H,5-8H2,1H3

Standard InChI Key:  UQIOJCBARSSJKK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
    2.2125   -5.1250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6917   -4.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2500   -5.7250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1667   -5.1250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6917   -4.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2125   -5.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7292   -4.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2500   -5.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7292   -6.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2042   -3.9167    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    3.7667   -6.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6542   -4.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1667   -3.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6542   -4.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  8  1  0
  4  2  2  0
  5  2  1  0
  6  1  1  0
  7  1  1  0
  8  7  1  0
  9  6  1  0
 10  5  1  0
 11  3  1  0
 12  4  1  0
 13  5  2  0
 14 13  1  0
  3  9  1  0
 12 14  2  0
M  END

Alternative Forms

Associated Targets(non-human)

ADRA2A Alpha-2a adrenergic receptor (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Alpha-1a adrenergic receptor (303 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra2c Adrenergic receptor alpha-2 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Cerebral cortex alpha adrenergic receptor (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha (950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 256.15Molecular Weight (Monoisotopic): 255.0371AlogP: 1.60#Rotatable Bonds: 1
Polar Surface Area: 19.37Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.17CX LogP: 2.07CX LogD: 2.05
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.76Np Likeness Score: -1.42

References

1. Saari WS, Halczenko W, King SW, Huff JR, Guare JP, Hunt CA, Randall WC, Anderson PS, Lotti VJ, Taylor DA..  (1983)  Pyridinylpiperazines, a new class of selective alpha 2-adrenoceptor antagonists.,  26  (12): [PMID:6139479] [10.1021/jm00366a007]

Source